https://www.biospace.com/casi-pharmaceuticals-announces-appointment-of-chief-financial-officer
CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer - BioSpace
Oct 1, 2018 - CASI Pharmaceuticals, Inc. announces the appointment of George Chi to the position of Chief Financial Officer.
chief financial officercasi pharmaceuticalsannouncesappointment
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/casi-pharmaceuticals-receives-and-appeals-delisting-determination-fro-1099368
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company ...
casi pharmaceuticalsreceivesappealsdelistingdetermination
https://investingnews.com/stocks/ncm-casi/casi-pharmaceuticals/
CASI Pharmaceuticals Stock Price, News, Quote & History | INN
Sep 11, 2025 - CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products...
casi pharmaceuticalsstock pricequote historynewsinn
https://www.biospace.com/casi-pharmaceuticals-announces-fourth-quarter-and-full-year-2022-financial-results
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS - BioSpace
Apr 26, 2023 - CASI Pharmaceuticals, Inc. today reported financial results for the year ended December 31, 2022, and provided an update on key highlights for 2022.
casi pharmaceuticalsfourth quarter
https://www.biospace.com/casi-pharmaceuticals-to-present-at-the-27th-annual-b-roth-b-conference
CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference - BioSpace
casi pharmaceuticalspresent
https://www.biospace.com/casi-pharmaceuticals-announces-cnct19-cd19-car-t-receives-china-breakthrough-therapy-designation
CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough Therapy Designation...
Dec 23, 2020 - CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and...
casi pharmaceuticals
https://www.biospace.com/press-releases/casi-pharmaceuticals-appoints-david-cory-as-chief-executive-officer-to-lead-u-s-company-focused-on-clinical-development-of-cid-103-a-potential-best-in-class-anti-cd38-program
CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. Company Focused on...
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-provides-update-on-phase-2-trial-of-enmd-2076-in-fibrolamellar-carcinoma-300313638.html
CASI Pharmaceuticals Provides Update On Phase 2 Trial Of ENMD-2076 In Fibrolamellar Carcinoma
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet...